CNBX Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 7, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Market Capitalization	0	0	0	0	4	25
Market Cap Growth	372.42%	43.59%	-45.29%	-91.76%	-82.85%	-3.36%
Enterprise Value	1	2	1	2	6	24
Last Close Price	0.00	0.00	0.01	0.02	3.40	20.40
PS Ratio	-	-	1.48	0.86	142.76	-
PB Ratio	-0.12	-0.11	-0.08	-0.17	-2.62	13.81
P/TBV Ratio	-	-	-	-	-	13.81
EV/Sales Ratio	-	-	10.87	4.00	193.13	-
Debt / Equity Ratio	-0.44	-0.48	-0.52	-0.67	-1.08	0.48
Net Debt / Equity Ratio	-0.43	-0.47	-0.51	-0.60	-1.00	-0.28
Net Debt / EBITDA Ratio	-	-5.93	-2.48	-1.58	-0.60	0.22
Net Debt / FCF Ratio	-7.51	-6.90	-5.17	-10.79	-0.98	0.21
Asset Turnover	-	-	0.49	0.63	0.02	-
Quick Ratio	0.00	0.01	0.01	0.05	0.05	1.09
Current Ratio	0.01	0.01	0.01	0.09	0.08	1.25
Return on Equity (ROE)	-	-	-	-	-4289.36%	-178.94%
Return on Assets (ROA)	-1709.09%	-681.68%	-137.42%	-88.86%	-94.92%	-61.35%
Return on Capital Employed (ROCE)	16.10%	10.90%	23.50%	46.20%	181.00%	-144.00%
Earnings Yield	-143.88%	-113.36%	-360.41%	-1052.38%	-87.05%	-12.81%
FCF Yield	-	-61.85%	-127.26%	-31.92%	-39.30%	-10.00%
Buyback Yield / Dilution	-2258.06%	-199.69%	-242.76%	-621.77%	-5.92%	-2.95%